SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MEI Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline – MEIP

NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MEI Pharma, Inc. (“MEI” or the “Company”) (NASDAQ: MEIP) and certain of its officers. The class action, filed in United States District Court for the Southern District of California, and docketed under 20-cv-01543, is on behalf of a class consisting of all pe